Abstract
Catatonia is very rare in children and adolescents, seen in only 0.6% of the inpatient population. High-dose benzodiazepines are the first-line therapy for catatonia. However, there is limited research on alternative therapies for patients who fail to respond to high-dose benzodiazepines. The objective of this study is to review the available literature on the treatment of catatonia in children and adolescents and explore potential augmentation strategies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the American Academy of Child & Adolescent Psychiatry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
